Caregivers' attitudes toward blood-based biomarker testing for Alzheimer's disease.

ABSTRACT:

Introduction

We aimed to evaluate informal caregivers' attitudes toward undergoing and future implementation of blood-based biomarkers (BBBM) testing for Alzheimer's disease (AD).

Methods

We explored caregivers' perspectives, by combining an online survey (n = 107) with a subsequent focus group (n = 7). We used descriptive statistics and thematic content analysis to identify common themes in answers to open-ended survey questions and focus group data.

Results

Most caregivers (72.0%) favored BBBM for AD diagnosis. Provided with hypothetical scenarios, confidence in a normal result decreased significantly if experienced symptoms were more severe (mild: 78.5% vs. severe: 48.6%). Caregivers' attitudes toward BBBM for screening purposes significantly improved

SUBMITTER: Bolsewig K 

PROVIDER: S-EPMC10870798 | biostudies-literature | 2024 Jan-Mar

REPOSITORIES: biostudies-literature